Answers are grounded in this paper and cite their sources.
A conformationally restrained epothilone A analogue (3) with a short bridge between methyl groups at C6 and C8 was designed and synthesized. Preliminary biological evaluation indicates 3 to be only weakly active (IC50 = 8.5 microM) against the A2780 human ovarian cancer cell line.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: